Related Experiment Video
Updated: Jul 15, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Evolution of cortical metabolic abnormalities and their clinical correlates in Sturge-Weber syndrome
C Juhasz1, C E A Batista, D C Chugani
1Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, 3901 Beaubien Boulevard, Detroit, MI, USA. juhasz@pet.wayne.edu
Insights
Sturge-Weber syndrome (SWS) shows progressive brain metabolism changes before age 3, linked to increased seizure frequency. Some children experience metabolic recovery, suggesting a therapeutic window for SWS treatment.
Area of Science:
- Neuroscience
- Pediatric Neurology
- Medical Imaging
Background:
- Sturge-Weber syndrome (SWS) natural course and neurological progression are not well understood.
- Early SWS neurological symptoms are often progressive.
Purpose of the Study:
- To track longitudinal changes in brain glucose metabolism using PET scans in children with SWS.
- To correlate metabolic changes with clinical progression in early SWS.
Main Methods:
- 14 children with SWS underwent two PET scans over a mean follow-up of 1.2 years.
- Assessed longitudinal changes in cortical glucose hypometabolism extent.
- Correlated metabolic changes with age, seizure frequency, and hemiparesis.
Main Results:
- Progressive hypometabolism enlargement occurred in 6 younger children, associated with higher seizure frequency.
- Metabolic changes correlated with age-related increases in unaffected cortex metabolism.
- Two children showed decreased hypometabolism, one with hemiparesis resolution.
Conclusions:
- Detrimental metabolic changes in SWS occur before age 3, coinciding with increased cerebral metabolic demand.
- Progressive hypometabolism is linked to high seizure frequency in SWS.
- Partial metabolic recovery with neurological improvement suggests a therapeutic window in unilateral SWS.
Background:
The natural course of Sturge-Weber syndrome (SWS) is poorly understood, although neurological symptoms are often progressive.
Aims:
To track longitudinal changes in brain glucose metabolism measured with positron emission tomography (PET) and their relation to clinical changes during the early course of SWS.
Methods:
Fourteen children (age 3 months to 3.9 years at enrollment) with SWS and unilateral leptomeningeal angioma underwent two consecutive glucose metabolism PET scans with a mean follow-up time of 1.2 years. Longitudinal changes of the extent of cortical glucose hypometabolism on the angioma side were measured and correlated with age, clinical seizure frequency and hemiparesis.
Results:
An increase in the size of the hypometabolic cortex was seen in 6 children, coinciding with an age-related increase in cortical glucose metabolism measured in unaffected contralateral cortex. These 6 patients were younger both at the initial (mean age 0.75 vs. 2.8 years; p<0.001) and the second scan (mean age 1.8 vs. 4.2 years; p=0.001) than those with no change in the extent of hypometabolic cortex (n=6). The area of cortical hypometabolism decreased in the two remaining children, and this was associated with resolution of an initial hemiparesis in one of them. Seizure frequency between the two scans was higher in children who showed progressive enlargement of cortical hypometabolism, as compared to those with no progression (p=0.008).
Conclusions:
In SWS, detrimental metabolic changes occur before 3 years of age coinciding with a sharp increase of developmentally regulated cerebral metabolic demand. Progressive hypometabolism is associated with high seizure frequency in these children. However, metabolic abnormalities may remain limited or even partially recover later in some children with well-controlled seizures. Metabolic recovery accompanied by neurological improvement suggests a window for therapeutic intervention in children with unilateral SWS.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cerebral Edema ll: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Graves Disease II: Pathophysiology

